Skip to main content
Journal ArticleOPEN ACCESS

Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn's disease

Cochrane Database of Systematic Reviews (2017) 2017(1)
DOI: 10.1002/14651858.CD012288.pub2
2Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The objective of this review is to determine the factors that influence placebo response and remission rates in induction and maintenance trials of CD in which patients with active or quiescent disease were enrolled using the CDAI or Harvey-Bradshaw Index (HBI).

Cite

CITATION STYLE

APA

Jairath, V., Zou, G. Y., Parker, C. E., Macdonald, J. K., Mosli, M. H., Alameel, T., … Feagan, B. G. (2017). Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn’s disease. Cochrane Database of Systematic Reviews, 2017(1). https://doi.org/10.1002/14651858.CD012288.pub2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free